Screener

Eligibility screening

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors

Sponsored by Shanghai Allink Biotherapeutics Co., Ltd.Study detailsClinicalTrials.gov

2 US sites in FL, VA

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.